Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency

Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in Primates

(2013) Jeffrey R. Crosby et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity

(2012) F. PEYVANDI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Molecular Mechanisms Affecting Fibrin Structure and Stability

(2011) Susan T. Lord   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Biological determinants of bleeding in patients with heterozygous factor XI deficiency

(2011) Paul Guéguen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma

(2011) Laura D. Gray et al.   THROMBOSIS RESEARCH

Thrombin generation in patients with factor XI deficiency and clinical bleeding risk

(2010) L. RUGERI et al.   HAEMOPHILIA

Factor XI deficiency in humans

(2009) U. SELIGSOHN   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Factor XI deficiency--resolving the enigma?

(2009) P. H. B. Bolton-Maggs   Hematology-American Society of Hematology Education Program

Cellular Procoagulant Activity Dictates Clot Structure and Stability as a Function of Distance From the Cell Surface

(2008) Robert A. Campbell et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY